SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950123-11-013913
Filing Date
2011-02-15
Accepted
2011-02-14 19:02:37
Documents
2
Group Members
BIOADVANCE GP I, L.P.BIOADVANCE GP II, INC.BIOADVANCE VENTURES, L.P.QUAKER BIOVENTURES CAPITAL II, L.P.QUAKER BIOVENTURES CAPITAL II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G c12590sc13g.htm SC 13G 107730
2 EX-99.1 c12590exv99w1.htm EX-99.1 10671
  Complete submission text file 0000950123-11-013913.txt   120659
Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428 484-567-0130
NUPATHE INC. (Subject) CIK: 0001375200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85616 | Film No.: 11610144
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G